Navigation Links
Blind humans lacking rods and cones retain normal responses to non-visual effects of light
Date:12/13/2007

, the effect of light on melatonin secretion was examined. Melatonin is a hormone produced at night that influences arousal and is secreted in a cyclic fashion. Just like sighted individuals, the blind patient exhibited acute suppression of melatonin in response to light and was most sensitive to blue-light exposure.

Furthermore, blue light also shifted the timing of the circadian pacemaker and improved alertness, as measured by subjective scales, auditory reaction time, and changes in brain activity. While a few rods and/or cones may remain, Zaidi and colleagues have strong evidence to show that they contribute little, if at all, to these effects. Thus the authors were able to show that the effects were maximal in response to wavelengths of light that the retinal ganglion cells respond best to, and not the wavelength that the visual system detects best.

In the second patient, a different a set of tests was administered to assess the effects of light. First, the pupil-constriction response to various wavelengths and intensities of light was examined. Consistent with the major role of the pRGCs in mediating this response, pupillary contriction was stimulated most by blue light (~480 nm), the wavelength that pRGCs are most stimulated by.

Given that the non-visual responses to light appeared to be intact in this patient, the researchers were prompted to ask whether some minimal awareness of light might still be retained despite the inability to detect any response to light by conventional measures and the patients inability to see light. Remarkably, the patient was able to tell that the blue light, but not any other color, was switched on, demonstrating that the pRGCs also contribute to our ability to see light.

These results have a number of important implications for human vision and vision-related diseases. First, they suggest humans possess light-sensitive cells, apart from rods and cones, that are important for non-visual lig
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Can brain-injured, partially-blind stroke patients regain some of their lost vision?
2. New discovery may improve treatment of one of the worlds leading causes of blindness
3. Verizon Awards $1.5 Million Grant to Expand American Foundation for the Blinds Web Site for Seniors With Age-Related Vision Loss
4. Diabetes: A Top Cause of Blindness Among Adults
5. Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans
6. Survey Confirms Americans Have a True Blind Spot Regarding Their Eye Health - and the Real Danger of UV Rays
7. STEP HIV vaccine study to be unblinded
8. Gene therapy safety trial for childhood blindness under way
9. National Federation of the Blind to Award $100,000
10. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
11. Toddler Study Proves Humans Outsmart Apes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 ... pain on the side of the hip , which ... bursitis treatment in Manhattan. This treatment is now offered at ... which is also called trochanteric bursitis, occurs when the ... a fluid-filled sac in the hip, between the iliotibial ...
(Date:9/22/2014)... The concept of a whole eye transplant seems ... grant from the U.S. Department of Defense, researchers ... Medicine hope to someday make implantation of an ... eye transplant could be a holy grail for ... of ophthalmology and grant co-recipient with colleagues at ...
(Date:9/22/2014)... New York, US (PRWEB) September 22, 2014 ... Heartbeat Experts’ perspectives on stakeholder management needs for the ... speak with Heartbeat Experts on stakeholder strategies for any ... clinically meaningful points of differentiation within an increasingly crowded ... , The impact of identifying community-based thought ...
(Date:9/22/2014)... Va. (PRWEB) September 22, 2014 ... the nation’s leading nonprofit authority on the ... healthcare information exchange, announced findings from its recent ... Health Plan Identifier (HPID) within electronic transactions adopted ... (HIPAA). WEDI conducted the survey from August 20 ...
(Date:9/22/2014)... CareFlight Air & Mobile Services ... a new AS365 N3+ Dauphin, the latest version of ... which is based at Miami Valley Hospital ... air medical transport helicopters. , “We have a lot ... Health Vice President, Emergency, Trauma, and CareFlight. “We’ve been ...
Breaking Medicine News(10 mins):Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 2Health News:DNR Clinic Offers Hip Bursitis Treatment in Manhattan 3Health News:Looking ahead: Whole eye transplant under development 2Health News:Download HeartBeat Experts White Paper: Stakeholder Management for new Prostate Cancer Products 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3
... MDAn original and progressive report on health information ... online today, makes ground-breaking recommendations for new ... tensions that currently mar relationships between many HIT ... indemnity and error management of HIT systems. In ...
... November 11, 2010 A new study from researchers in ... more likely to undergo a screening colonoscopy than those who ... for female endoscopists seem to be common among women. In ... notion that rates of screening colonoscopy can be increased by ...
... , THURSDAY, Nov. 11 (HealthDay News) -- U.S. ... to binge-drink, smoke cigarettes or use illicit drugs, a new ... likely to abuse prescription drugs, according to the Center ... from an analysis of 2002 to 2009 data from the ...
... in French . , Montreal, November 11, 2010 ... additional cardiac test when undergoing diagnosis for potential heart problems, ... du Qubec Montral and the Montreal Heart Institute. ... Journal of Cardiopulmonary Rehabilitation and Prevention , a large sample ...
... By Jenifer Goodwin HealthDay Reporter , ... synthetic marijuana known as "K2" is sending young people ... and hallucinations, toxicologists warn. In recent months, physicians ... up in emergency rooms after smoking synthetic marijuana. Despite ...
... chemist Dr Guillaume Lessene has been awarded the Walter and ... annual general meeting in Melbourne, Australia. The $AUD150,000 ... played in shaping the Walter and Eliza Hall Institute. It ... Burgh in August at the age of 94. ...
Cached Medicine News:Health News:Fortify HIT contracts with education and ethics to protect patient safety, say informatics experts 2Health News:Fortify HIT contracts with education and ethics to protect patient safety, say informatics experts 3Health News:Screening colonoscopy rates are not increased when women are offered a female endoscopist 2Health News:Screening colonoscopy rates are not increased when women are offered a female endoscopist 3Health News:Screening colonoscopy rates are not increased when women are offered a female endoscopist 4Health News:Additional cardiac testing vital for patients with anxiety and depression 2Health News:'Fake Marijuana' Users Showing Up in Emergency Rooms 2Health News:'Fake Marijuana' Users Showing Up in Emergency Rooms 3Health News:Medicinal chemist wins inaugural De Burgh Fellowship 2
(Date:9/22/2014)... Inc. (NYSE MKT: CUR) announced that Jonathan D. ... long-term follow up data on the Phase I trial ... of amyotrophic lateral sclerosis (ALS or Lou Gehrig,s ... Symposium on ALS of the Foundation Andre-Delambre, in ... not open to the public, covered data up to ...
(Date:9/22/2014)... 22, 2014  AbbVie (NYSE: ABBV ... evaluating potential new medicines in the company,s oncology ... European Society of Medical Oncology (ESMO) Annual Congress, ... . Data being presented include results from a ... of veliparib (ABT-888), a poly (adenosine diphosphate [ADP]–ribose) ...
(Date:9/22/2014)... CAMBRIDGE, Mass. , Sept. 22, 2014  Seres ... diseases related to the human microbiome, today announced that ... one of 2014,s Fierce 15 biotechnology companies, designating it ... in the industry.  "Amid a great ... out for its focus and commitment to practical therapeutic ...
Breaking Medicine Technology:Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Seres Health Named a "Fierce 15" Biotech Company for 2014 2
... Barry Edison announces that Barry Edison Ophthalmology in ... Pelleve® Wrinkle Reduction System, a revolutionary skin-tightening system ... uses Pelleve—an advanced radiofrequency technology—because the treatment delivers ... results. "I am proud to now offer Pelleve ...
... 22, 2012  Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. ... Phase 3 trial evaluating Nexavar ® (sorafenib) tablets ... cell lung cancer (NSCLC) whose disease progressed after two ... endpoint of improving overall survival.  An improvement in the ...
Cached Medicine Technology:New Jersey Ophthamologist Now Offers Pelleve Wrinkle Reduction Treatment 2Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival 2Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival 3Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival 4Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival 5Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival 6
... For enzyme immunoassays, designed to meet the ... and allows the user to run set ... The floating manifold on this strip washer ... at a time. Reliable, compact, and self-contained, ...
... available to handle multiple assays: ... Embla 384 Cell washer has ... optimized to avoid cell disturbance. ... and have been integrated with ...
... miniGene LW is a new plate washing system ... and 384 channel microplates with flat, V-shaped or ... 8 or 16 channel nozzle heads. Simple LCD ... An optional plate stacker is available for the ...
Space-saving counter top model,User initiated manual defrost,Standard features (see above),Internal freezing compartment,Removable half-shelf in refrigerator,Two shelves in door,UL 471 Commercial Ref...
Medicine Products: